Your browser doesn't support javascript.
loading
The combination of an inclusive novel agent treatment strategy, pre-emptive therapy dose reduction, and prolonged therapy results in good outcomes in elderly myeloma patients.
Ediriwickrama, Nadishani; Oyebamiji, Titi; Munisamy, Sreetharan; Garland, Paula; Cuthill, Kirsty; Benjamin, Reuben; Ceesay, M Mansour; Bowcock, Stella.
Affiliation
  • Ediriwickrama N; Princess Royal University Hospital, King's College Hospital NHS Trust, Orpington, London, UK.
  • Oyebamiji T; Princess Royal University Hospital, King's College Hospital NHS Trust, Orpington, London, UK.
  • Munisamy S; Princess Royal University Hospital, King's College Hospital NHS Trust, Orpington, London, UK.
  • Garland P; Princess Royal University Hospital, King's College Hospital NHS Trust, Orpington, London, UK.
  • Cuthill K; Princess Royal University Hospital, King's College Hospital NHS Trust, Orpington, London, UK.
  • Benjamin R; Princess Royal University Hospital, King's College Hospital NHS Trust, Orpington, London, UK.
  • Ceesay MM; Princess Royal University Hospital, King's College Hospital NHS Trust, Orpington, London, UK.
  • Bowcock S; Princess Royal University Hospital, King's College Hospital NHS Trust, Orpington, London, UK.
Br J Haematol ; 186(3): e11-e13, 2019 08.
Article in En | MEDLINE | ID: mdl-30864155

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma / Antineoplastic Agents Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Br J Haematol Year: 2019 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma / Antineoplastic Agents Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Br J Haematol Year: 2019 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom